A genetic diagnostic test for detecting the Factor II mutation (G20210A) associated with thrombophilia risk. Factor II is a key coagulation factor, and this mutation increases predisposition to thrombotic events. The kit contains reagents for 32 tests and is compatible with QiaSymphony SP/AP extract...
Manufactured by
Abbiategrasso, Italy
Since 1987, Clonit has been focused in developing, manufacturing and distributing of innovative and reliable in Vitro Diagnostic Equipment and Reagents for Molecular Diagnostics. A deep expertise in Molecular Biology mixed to our strong culture of business ethics make our company a valued partner for laboratories and hospitals around the world. With our high standard and high performance IVDs portfolio, we aim to improve healthcare by enhancing and supporting the decision-making process, in line with scientific and technological evolution. Our clinical diagnostic products are used to detect a broad range of diseases in several key areas such as viral, bacterial and fungal infections (including sexually transmitted diseases, transplantation/immunocompromised related infections, tropical diseases, healthcare associated infections), thrombophilia, oncohematology and several genetic disorders . The standardization of internal quality control system and cross-checks in external reference labs allow Clonit to ensure application of the highest standards of care and quality (ISO 9001 and ISO 13485 Certified). Recently Clonit obtained the certification of products according to EU 2017/746 Regulation on In Vitro Diagnostic Medical Devices (IVDR). Certification for Class C products was issued by TÜV SÜD Product Service The company is registered and authorized by the Italian Ministry of the Health for the development, manufacturing and commercialization of Medical Diagnostic devices. We listen carefully to our customers’ needs and work closely with health care professionals to transform them into solutions that provide people a better quality of life.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
GMA Group Trading
Egypt · 2 relevant products
Attomol GmbH - Molekulare Diagnostika
Germany · 20 relevant products
BEACON DIAGNOSTICS PVT. LTD.
India · 1 relevant product
Lansion Biotechnology Co., Ltd.
China · 1 relevant product
He Bei GuoGao BiotechnoLogy co .,ltd
China · 1 relevant product
GENERI BIOTECH s.r.o.
Czech Republic · 4 relevant products
Advanced Molecular Diagnostics Ltd.
United Kingdom · 5 relevant products
Shanghai Sun Biotech Co., Ltd
China · 7 relevant products
Operon S.A.
Spain · 1 relevant product
Diagnostica Stago, Inc.
United States · 2 relevant products
16 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →4 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 77 closest product alternatives
GMA Group Trading · Egypt
Molecular test for detecting thrombophilia-related genetic mutations in coagulation factors F2 and F5.
Attomol GmbH - Molekulare Diagnostika · Germany
A diagnostic test kit for detecting the Prothrombin mutation (Factor II 20210G>A). The kit is designed for molecular genetic analysis and contains 40 test determinations. This test is used to identify genetic variations associated with increased thrombotic risk.
Attomol GmbH - Molekulare Diagnostika · Germany
A diagnostic test kit for detecting the Prothrombin mutation (Factor II 1991 1A>G). The kit contains 20 test determinations and is used for molecular genetic screening of this factor II variant.
GMA Group Trading · Egypt
Genetic susceptibility testing for thrombophilia risk assessment using SNP analysis.
Attomol GmbH - Molekulare Diagnostika · Germany
Real-time PCR diagnostic test kit for simultaneous detection of Prothrombin 20210G>A and Factor V Leiden mutations. Available with 20 or 100 determinations.
BEACON DIAGNOSTICS PVT. LTD. · India
Test kit for assessment of blood coagulation factors and platelet function. Evaluates hemostatic disorders and monitors anticoagulation therapy.
Lansion Biotechnology Co., Ltd. · China
In vitro diagnostic reagent for blood coagulation assessment. Supports rapid evaluation of clotting factors and function.
He Bei GuoGao BiotechnoLogy co .,ltd · China
A diagnostic test kit for measuring fibrinogen levels. This product is used in coagulation testing.
GENERI BIOTECH s.r.o. · Czech Republic
CE IVD real-time PCR kit for detection of CYP2C9 polymorphisms (*2A, *13, HapB3, c2846A>T) according to CPIC and DPWG guidelines. Enables personalized dosing of warfarin and other CYP2C9-metabolized medications.
Attomol GmbH - Molekulare Diagnostika · Germany
Real-time PCR diagnostic test kit for the detection of Prothrombin mutation 20210G>A. Available with 48 or 96 determinations.
Advanced Molecular Diagnostics Ltd. · United Kingdom
Molecular diagnostic kit for detecting Factor II G20210A mutation associated with thrombophilia risk. Supports genetic testing for blood clotting disorders.
Shanghai Sun Biotech Co., Ltd · China
Complete diagnostic testing kit for thrombosis assessment and risk stratification. This product enables rapid identification of thrombotic conditions in clinical settings.
65 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products